Cargando…
Therapeutics—how to treat phase separation-associated diseases
Liquid–liquid phase separation has drawn attention as many neurodegeneration or cancer-associated proteins are able to form liquid membraneless compartments (condensates) by liquid–liquid phase separation. Furthermore, there is rapidly growing evidence that disease-associated mutation or post-transl...
Autor principal: | Wheeler, Richard John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733670/ https://www.ncbi.nlm.nih.gov/pubmed/32364240 http://dx.doi.org/10.1042/ETLS20190176 |
Ejemplares similares
-
Phase separation as a therapeutic target in tight junction-associated human diseases
por: Sun, Shuang, et al.
Publicado: (2020) -
How Do Flaviviruses Hijack Host Cell Functions by Phase Separation?
por: Saito, Akatsuki, et al.
Publicado: (2021) -
Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation
por: Lim, Christine M., et al.
Publicado: (2023) -
Physics of compartmentalization: How phase separation and signaling shape membrane and organelle identity
por: Floris, Elisa, et al.
Publicado: (2021) -
Liquid–Liquid Phase Separation in Cardiovascular Diseases
por: Mo, Yuanxi, et al.
Publicado: (2022)